Chapters
| Status | Drug name | NICE TAs | Comments |
|---|---|---|---|
|
Amitriptyline |
(Off label). Low abuse, low cost |
|
|
|
Amitriptyline#4.7 |
Anti-migraine |
|
|
|
Aspirin 300mg dispersible tablets |
Topical analgesia - for gargling |
|
|
Aspirin suppositories | ||
|
|
Atogepant (Aquipta®) |
Use in accordance with NICE |
|
|
|
Botox A | ||
|
Buprenorphine patches |
Specialist initiation only. Patches must be prescribed by brand. |
|
|
|
Buprenorphine S/L tablets |
Specialist initiation only |
|
|
|
Capsaicin cream 0.075% |
Only strength licensed for post-herpetic neuralgia and diabetic peripheral polyneuropathy. |
|
|
|
Carbamazepine |
Trigeminal neuralgia only |
|
|
|
Co-codamol 30/500 capsules |
Wherever possible, avoid theu se of combination products. Use paracetamol and codeine separately. All combination products of paracetamol and codeine/dihydrocodeine are deemed products less suitable for prescribing in the BNF. Capsules have a very high relative cost. Sodium content. Only if swallowing difficulties. |
|
|
|
Co-codamol 30/500 effervescent tablets |
Wherever possible, avoid theu se of combination products. Use paracetamol and codeine separately. All combination products of paracetamol and codeine/dihydrocodeine are deemed products less suitable for prescribing in the BNF. Capsules have a very high relative cost. Sodium content. Only if swallowing difficulties. |
|
|
|
Co-codamol 30/500 tablets |
Wherever possible, avoid theu se of combination products. Use paracetamol and codeine separately. All combination products of paracetamol and codeine/dihydrocodeine are deemed products less suitable for prescribing in the BNF. Capsules have a very high relative cost. Sodium content. Only if swallowing difficulties. |
|
|
|
Codeine phosphate 25mg/5ml syrup | ||
|
|
Codeine phosphate 60mg/1ml injection | ||
|
|
Codeine phosphate tablets | ||
|
|
Diamorphine hydrochloride injection | ||
|
|
Dihydrocodeine solution |
For patients with swallowing difficulties |
|
|
|
Dihydrocodeine tablets | ||
|
|
Dihydroergotamine IV | ||
|
|
Duloxetine | ||
|
|
Erenumab (Aimovig®) | ||
|
|
Fentanyl injection | ||
|
|
Fentanyl lozenges |
For palliative care use only |
|
|
|
Fentanyl patches | ||
|
|
Fentanyl sublinual tablets |
For palliative care use only |
|
|
|
Fetanyl nasal spray | ||
|
|
Flunarazine tablets |
Not licensed in the UK. Licensed in Europe and Ireland - preventative management in primary headache. |
|
|
|
Fremanezumab (Ajovy®) | ||
|
|
Gabapentin capsules |
Second line - please be aware of the abuse potential associated with this class of agent - see NHS England advice. |
|
|
|
Gabapentin tablets |
Second line - please be aware of the abuse potential associated with this class of agent - see NHS England advice. |
|
|
|
Lidocaine 5% patch |
For patients who have been treated in line with NICE CG173 Neuropathic pain in adults: pharmacological management in non-specialist settings but are still experiencing neuropathic pain associated with previous herpes zoster infection (post-herpetic neuralgia) |
|
|
|
Meptazinol | ||
|
|
Meptazinol (Meptid®) |
HGS only |
|
|
|
Migraleve® pink | ||
|
|
Morphine Sulfate orodispersible tablets (Actimorph®) |
For use in Palliative patients only |
|
|
|
Morphine sulphate 100mg/100ml PCA | ||
|
|
Morphine sulphate 100mg/5ml solution | ||
|
|
Morphine sulphate 10mg/5ml solution | ||
|
|
Morphine sulphate 5mg/5ml intrathecal injection |
For West Midlands Rehab Unit only |
|
|
|
Morphine sulphate injection | ||
|
|
Morphine sulphate M/R capsules |
Zomorph |
|
|
|
Morphine sulphate M/R sachets |
MST continus |
|
|
|
Morphine sulphate M/R tablets | ||
|
|
Morphine sulphate suppositories | ||
|
|
Morphine sulphate tablets | ||
|
|
Oxycodone hydrochloride capsules |
Lynlor capsules preferred brand |
|
|
|
Oxycodone hydrochloride injection | ||
|
|
Oxycodone hydrochloride M/R tablets |
Reltebon MR tablets preferred brand |
|
|
|
Oxycodone hydrochloride SF solution | ||
|
|
Paracetamol 1000mg/100ml infusion | ||
|
|
Paracetamol SF suspension | ||
|
|
Paracetamol soluble tablets |
High sodium content - only if swallowing difficulties. |
|
|
|
Paracetamol suppositories | ||
|
|
Paracetamol tablets | ||
|
|
Pethidine injection | ||
|
|
Pizotifen elixir | ||
|
|
Pizotifen tablets | ||
|
|
Pregabalin#4.7 |
4th line after duloxetine. Advice of specialist if duloxetine is unsuitable. Please be aware of the abuse potential associated with this class of agent - See NHS England advice. Prescribers should prescribe generically. |
|
|
|
Propranolol |
Anti-migraine |
|
|
Rimegepant | ||
|
|
Rizatriptan tablets |
Reserved for patients who are vomiting due to migraine |
|
|
|
Sumatriptan 6mg/0.5ml syringe (plus auto-injector) | ||
|
|
Sumatriptan nasal spray | ||
|
|
Sumatriptan tablets | ||
|
|
Topiramate tablets |
Prophylaxis of migraine. Specialist recommendation. |
|
|
|
Tramadol capsules |
Second line after morphine and codeine. Soluble tablets - high relative cost - patients with swallowing difficulties. |
|
|
|
Tramadol soluble tablets |
Second line after morphine and codeine. Soluble tablets - high relative cost - patients with swallowing difficulties. |
|
|
|
Zolmitriptan |
Tablets, orodispersible tablets and nasal spray |
